Health ❯ Healthcare ❯ Patient Care

Chronic Diseases

Diabetes Management Vision Loss Type 2 Diabetes Obesity Management Heart Disease Cancer Treatment Fatty Liver Disease Financial Relief Management of Multiple Sclerosis Obesity

Pfizer’s Oral Drug Shows Strong Phase 3 Results in Nonsegmental Vitiligo

The company says the medicine delivered meaningful facial and total-body repigmentation and will pursue regulatory approval for adult patients.

Lilly’s Experimental Triple-Agonist Retatrutida Produces Weight Loss Comparable to Bariatric Surgery in Phase 3

Roche Files MS Drug Fenebrutinib With Regulators Despite Trial Deaths

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

AstraZeneca’s COPD Antibody Tozorakimab Succeeds in Two Phase 3 Trials

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

Fuji Rebio Seeks Japan Approval for Blood Test to Aid Alzheimer’s Diagnosis

Roche’s Oral BTK Drug Succeeds in Phase 3 MS Trials, Matching Ocrevus in Progressive Disease

Wegovy Launches in Argentina With Adolescent Indication and Proven Cardiovascular Benefit

Study Finds COPD Patients Report High Burden but Few Detailed Talks With Clinicians

FDA Approves Papzimeos as First Therapy for Adult Recurrent Respiratory Papillomatosis

Italian Internal Medicine Wards Face Overcrowding and Staffing Crisis